122 related articles for article (PubMed ID: 37967234)
1. Effect and Interactions of BRAF on Lymph Node Metastasis in Papillary Thyroid Carcinoma With Hashimoto Thyroiditis.
Li P; Liu Y; Wei T; Wang X; Zhu J; Yang R; Gong Y; Zhao W
J Clin Endocrinol Metab; 2024 Mar; 109(4):944-954. PubMed ID: 37967234
[TBL] [Abstract][Full Text] [Related]
2. A nomogram model based on the preoperative clinical characteristics of papillary thyroid carcinoma with Hashimoto's thyroiditis to predict central lymph node metastasis.
Zhao W; He L; Zhu J; Su A
Clin Endocrinol (Oxf); 2021 Feb; 94(2):310-321. PubMed ID: 32984984
[TBL] [Abstract][Full Text] [Related]
3. Integrating BRAF
Zhang Z; Zhang X; Yin Y; Zhao S; Wang K; Shang M; Chen B; Wu X
BMC Cancer; 2022 Apr; 22(1):461. PubMed ID: 35473554
[TBL] [Abstract][Full Text] [Related]
4. Potential relationship between Hashimoto's thyroiditis and BRAF(V600E) mutation status in papillary thyroid cancer.
Zeng RC; Jin LP; Chen ED; Dong SY; Cai YF; Huang GL; Li Q; Jin C; Zhang XH; Wang OC
Head Neck; 2016 Apr; 38 Suppl 1():E1019-25. PubMed ID: 26041461
[TBL] [Abstract][Full Text] [Related]
5. The Underestimated Impact of Hashimoto Thyroiditis on Thyroid Papillary Carcinoma.
Harmantepe AT; Ozdemir K; Bayhan Z; Kocer B
Updates Surg; 2024 Jun; 76(3):1085-1089. PubMed ID: 38687448
[TBL] [Abstract][Full Text] [Related]
6. Younger Than 55 Years Old and
Lai Y; Gu Y; Yu M; Deng J
Int J Gen Med; 2023; 16():1403-1414. PubMed ID: 37155469
[TBL] [Abstract][Full Text] [Related]
7. Integrating US-guided FNAB, BRAF
Ma N; Tian HY; Yu ZY; Zhu X; Zhao DW
Eur Arch Otorhinolaryngol; 2023 Dec; 280(12):5565-5574. PubMed ID: 37540271
[TBL] [Abstract][Full Text] [Related]
8. Combined effect of Hashimoto's thyroiditis and BRAF(V600E) mutation status on aggressiveness in papillary thyroid cancer.
Kim SJ; Myong JP; Jee HG; Chai YJ; Choi JY; Min HS; Lee KE; Youn YK
Head Neck; 2016 Jan; 38(1):95-101. PubMed ID: 25213729
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of the effect of Hashimoto's thyroiditis on the diagnostic efficacy of preoperative ultrasonography on cervical lymph node lesions in papillary thyroid cancer.
Tan HL; Nyarko A; Duan SL; Zhao YX; Chen P; He Q; Zhang ZJ; Chang S; Huang P
Front Endocrinol (Lausanne); 2022; 13():987906. PubMed ID: 36714580
[TBL] [Abstract][Full Text] [Related]
10. Association between diffuse lymphocytic infiltration and papillary thyroid cancer aggressiveness according to the presence of thyroid peroxidase antibody and BRAF
Lee YK; Park KH; Park SH; Kim KJ; Shin DY; Nam KH; Chung WY; Lee EJ
Head Neck; 2018 Oct; 40(10):2271-2279. PubMed ID: 29935011
[TBL] [Abstract][Full Text] [Related]
11. A retrospective study of papillary thyroid carcinoma: Hashimoto's thyroiditis as a protective biomarker for lymph node metastasis.
Wang Y; Zheng J; Hu X; Chang Q; Qiao Y; Yao X; Zhou X
Eur J Surg Oncol; 2023 Mar; 49(3):560-567. PubMed ID: 36404253
[TBL] [Abstract][Full Text] [Related]
12. [Association between BRAF V600E mutation and central lymph node metastasis in patients with papillary thyroid carcinoma].
Shi C; Qin H; Ding C; Sun Y; Lyu Y; Shi T
Zhonghua Zhong Liu Za Zhi; 2015 Feb; 37(2):123-7. PubMed ID: 25975689
[TBL] [Abstract][Full Text] [Related]
13. The characteristics and risk factors of central compartment lymph node metastasis in cN0 papillary thyroid carcinoma coexistent with Hashimoto's thyroiditis.
Jin K; Li L; Liu Y; Wang X
Gland Surg; 2020 Dec; 9(6):2026-2034. PubMed ID: 33447553
[TBL] [Abstract][Full Text] [Related]
14. Predicting factors of central lymph node metastasis and BRAF
Zhou SL; Guo YP; Zhang L; Deng T; Xu ZG; Ding C; Sun WC; Zhao YW; Kong LF
World J Surg Oncol; 2021 Jul; 19(1):211. PubMed ID: 34256769
[TBL] [Abstract][Full Text] [Related]
15. Hashimoto's Thyroiditis Minimizes Lymph Node Metastasis in
Issa PP; Omar M; Buti Y; Issa CP; Chabot B; Carnabatu CJ; Munshi R; Hussein M; Aboueisha M; Shama M; Corsetti RL; Toraih E; Kandil E
Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009596
[TBL] [Abstract][Full Text] [Related]
16. Influence of coexistent Hashimoto's thyroiditis on the extent of cervical lymph node dissection and prognosis in papillary thyroid carcinoma.
Song E; Jeon MJ; Park S; Kim M; Oh HS; Song DE; Kim WG; Kim WB; Shong YK; Kim TY
Clin Endocrinol (Oxf); 2018 Jan; 88(1):123-128. PubMed ID: 28906015
[TBL] [Abstract][Full Text] [Related]
17. The Impact of Coexistent Hashimoto's Thyroiditis on Central Compartment Lymph Node Metastasis in Papillary Thyroid Carcinoma.
Liu Y; Lv H; Zhang S; Shi B; Sun Y
Front Endocrinol (Lausanne); 2021; 12():772071. PubMed ID: 34867817
[TBL] [Abstract][Full Text] [Related]
18. Clinical and pathological features and the BRAF(V600E) mutation in patients with papillary thyroid carcinoma with and without concurrent Hashimoto thyroiditis.
Kim SK; Song KH; Lim SD; Lim YC; Yoo YB; Kim JS; Hwang TS
Thyroid; 2009 Feb; 19(2):137-41. PubMed ID: 19014278
[TBL] [Abstract][Full Text] [Related]
19. Hashimoto's Thyroiditis: A Protective Factor against Recurrence in BRAF-Wild Type Differentiated Thyroid Carcinoma.
Issa PP; Omar M; Buti Y; Aboueisha M; Munshi R; Hussein M; Haidari M; Blair G; Issa CP; Shama M; Toraih E; Kandil E
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190300
[TBL] [Abstract][Full Text] [Related]
20. Risk and Prognostic Factors for BRAF
Wei X; Wang X; Xiong J; Li C; Liao Y; Zhu Y; Mao J
Biomed Res Int; 2022; 2022():9959649. PubMed ID: 35647194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
